Investor Presentation for NSE and BSE Stocks - Q2FY22

Investor Presentations: Get insights into company performance, financials, capex plans for NSE and BSE stocks - Q2FY22

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
C
Cords Cable Industries Ltd.
12 Sep 2022
176.63
0.82%
CORDS CABLE INDUSTRIES LTD. - 532941 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, This has reference to Regulation-30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Please find the attached Investor Presentation for the Quarter ended September 30th , 2022. The above mentioned Investor Presentation will also be available on website of the company. Request you to take the same on records.
pdf
logo
International Conveyors Ltd.
12 Sep 2022
97.62
1.40%
pdf
logo
ICICI Bank Ltd.
09 Sep 2022
1401.60
-0.16%
pdf
logo
Shakti Pumps (India) Ltd.
09 Sep 2022
809.00
-0.50%
pdf
logo
Precision Camshafts Ltd.
08 Sep 2022
221.56
-4.80%
pdf
logo
Aurum Proptech Ltd.
08 Sep 2022
172.66
0.84%
pdf
logo
Shreeji Translogistics Ltd.
08 Sep 2022
pdf
logo
Shreeji Translogistics Ltd.
08 Sep 2022
pdf
logo
Bal Pharma Ltd.
07 Sep 2022
90.32
2.21%
pdf
logo
Aurobindo Pharma Ltd.
07 Sep 2022
1109.20
5.61%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Further to our letter dated September 6, 2022 informing about the participation in the Kotak Institutional Equity Healthcare Forum 2022 on September 8, 2022, we inform you that the presentation updated in the following weblink of the Company will be used during the interaction with the investors. https://www.aurobindo.com/wp-content/uploads/2022/09/Aurobindo-Pharma_Investor-Presentation_INR_Sep-22.pdf No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
pdf